Overland Park, Kansas – April 7, 2016 – KYBELLA® (deoxycholic acid) injection 10 mg/mL, the first and only FDA-approved injectable treatment that physically destroys fat under the chin for an improved profile,1 is now available in Kansas City. Submental fullness, also known as “double chin,” is a common concern among facial aesthetic oriented patients2 and can impact both men and women. Some possible causes are genetics, weight gain and aging.3, 4
Sometimes, even with diet or exercise, unwanted fullness beneath the chin may not go away, and it can make a person appear older or heavier than they actually are.5 According to a 2015 survey by the American Society for Dermatologic Surgery (ASDS), more than two thirds of aesthetic-oriented consumers are bothered by submental fullness – nearly as many as those bothered by lines and wrinkles around the eyes.2
KYBELLA® is given during a series of in-office visits. The injection process may take 15 to 20 minutes. The active ingredient in KYBELLA® is deoxycholic acid, a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat.1, 6 Fat cleared from the treatment area is processed through the body’s natural metabolic pathways.7
Treatment with KYBELLA® is tailored by the doctors to the individual patient’s submental fat distribution and aesthetic goals for an improved chin profile.1
Kybella can cause serious side effects, including nerve injury in the jaw (which can cause an uneven smile or facial muscle weakness), and trouble swallowing. The most common side effects are swelling, bruising, pain, numbness, redness, and areas of hardness in the treatment area.1 In clinical trials, the incidence and severity of most side effects decreased with subsequent KYBELLA® treatments.8
As part of a clinical development program, KYBELLA® has been evaluated in more than 20 clinical studies. More than 1,600 people around the world have been treated with KYBELLA®.8
To learn more, please visit www.mykybella.com
To schedule a consultation, please call 913-387-1104
What is KYBELLA®?
KYBELLA® is a prescription medicine used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called “double chin.”
It is not known if KYBELLA® is safe and effective for use outside of the submental area or in children under the age of 18.
Who should not receive KYBELLA®?
One should not receive KYBELLA® if they have an infection in the treatment area.
Before receiving KYBELLA®, tell the healthcare provider about all the medical conditions,
Which includes: Have had or plan to have surgery on the face, neck, or chin; have had cosmetic treatments on the face, neck, or chin; have had or have medical conditions in or near the neck area; have had or have trouble swallowing; have bleeding problems; are pregnant or plan to become pregnant (it is not known if KYBELLA® will harm the unborn baby); are breastfeeding or plan to breastfeed (it is not known if KYBELLA® passes into the breast milk; talk to the healthcare provider about the best way to feed a baby if mother receive KYBELLA®).
Tell the healthcare provider about all the medicines that one takes, including prescription and over-the counter medicines, vitamins, and herbal supplements. Especially tell the healthcare provider if one takes a medicine that prevents the clotting of the blood (antiplatelet or anticoagulant medicine).
What are the possible side effects of KYBELLA®?
KYBELLA® can cause serious side effects, including nerve injury in the jaw (which can cause an uneven smile or facial muscle weakness), or trouble swallowing.
The most common side effects of KYBELLA® include: swelling, bruising, pain, numbness, redness, and areas of hardness in the treatment area.
These are not all of the possible side effects of KYBELLA®. Call the healthcare provider for medical advice about side effects.
© 2016 Allergan. All rights reserved. All trademarks are the property of their respective owners.
1 KYBELLA® Product Label, 2015
2 American Society for Dermatologic Surgery 2015 Consumer Survey on Cosmetic Dermatologic Procedures (N=7,315); Exact survey language was, “How bothered are you by excess fat under the chin/neck?” 2015
3 Rzany. “Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic.” 2013
4 DeFatta R, Ducic Y. “Liposuction of the face and neck. Operative Techniques in Otolaryngology.” 2007
5 Chubaty, Duncan. Aesthetic Surgery Journal, “Clinical Safety Data and Standards of Practice for Injection Lipolysis: A Retrospective Study.” 2006
6 Thuangtong, Rattapon. “Tissue-Selective Effects of Injected Deoxycholate.” 2010
7 Rotunda, Adam. “Injectable Treatments for Adipose Tissue: Terminology, Mechanism, and Tissue Interaction.” 2009
8 Center for Drug Evaluation and Research, MEDICAL REVIEW(S). 2014
Distributed by RSVP Med Spa
Company Name: RSVP Med Spa
Contact Person: Jamie Osteen
Address:13300 Metcalf Ave.
City: Overland Park
Country: United States